litlas
Log inCreate account

Peter J. Elliott

Active 1982–2020

74
Papers
26,501
Citations
68
h-index
74
i10-index

Citations

Citations per year for Peter J. Elliott1962: 1 citations1971: 1 citations1984: 3 citations1985: 5 citations1986: 4 citations1987: 4 citations1988: 3 citations1989: 7 citations1990: 7 citations1991: 8 citations1992: 5 citations1993: 7 citations1994: 11 citations1995: 18 citations1996: 32 citations1997: 39 citations1998: 20 citations1999: 53 citations2000: 67 citations2001: 118 citations2002: 204 citations2003: 300 citations2004: 322 citations2005: 291 citations2006: 324 citations2007: 270 citations2008: 351 citations2009: 515 citations2010: 622 citations2011: 561 citations2012: 522 citations2013: 421 citations2014: 433 citations2015: 320 citations2016: 321 citations2017: 262 citations2018: 270 citations2019: 704 citations2020: 780 citations2021: 659 citations2022: 477 citations2023: 349 citations2024: 473 citations2025: 233 citations2026: 5 citations1963–1970: no citations, so these years are not shown1972–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,161 citing papers, 30% of this breakdownChina: 1,422 citing papers, 13.5% of this breakdownUnited Kingdom: 522 citing papers, 5% of this breakdownItaly: 464 citing papers, 4.4% of this breakdownGermany: 430 citing papers, 4.1% of this breakdownCanada: 352 citing papers, 3.3% of this breakdownJapan: 318 citing papers, 3% of this breakdownFrance: 317 citing papers, 3% of this breakdownSpain: 303 citing papers, 2.9% of this breakdownSouth Korea: 242 citing papers, 2.3% of this breakdownIndia: 241 citing papers, 2.3% of this breakdownAustralia: 228 citing papers, 2.2% of this breakdown
0%30%Other 24%

Institutions

Fields

  • Medicine55%
  • Biochemistry, Genetics and Molecular Biology32.5%
  • Neuroscience5%
  • Computer Science2.1%
  • Immunology and Microbiology1.8%
  • Agricultural and Biological Sciences0.8%
  • Other2.8%

Topics

  • Sirtuins and Resveratrol in Medicine9.8%
  • Adipose Tissue and Metabolism6.6%
  • Autophagy in Disease and Therapy4%
  • Ubiquitin and proteasome pathways3.1%
  • Mitochondrial Function and Pathology2.6%
  • Genetics, Aging, and Longevity in Model Organisms1.7%
  • Other72.2%

Coauthors

All papers

Open in search
  1. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

    Authors: Carles Cantó, Zachary Gerhart‐Hines, Jérôme N. Feige, Marie Lagouge, Lilia G. Noriega, Jill C. Milne, Peter J. Elliott, Pere Puigserver, Johan Auwerx - Nature 2009 cited by 3,267

  2. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α

    Authors: Marie Lagouge, Carmen Argmann, Zachary Gerhart‐Hines, Hamid Méziane, Carles Lerín, Frédéric Daussin, Nadia Messadeq, Jill C. Milne, Philip Lambert, Peter J. Elliott, Bernard Gény, Markku Laakso, Pere Puigserver, Johan Auwerx - Cell 2006 cited by 4,011

  3. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

    Authors: Jill C. Milne, Philip Lambert, Simon Schenk, David P. Carney, J. Joshua Smith, David Gagné, Lei Jin, Olivier Boss, Robert B. Perni, Chi B. Vu, Jean E. Bemis, Roger L. Xie, Jeremy S. Disch, Pui Yee Ng, Joseph J. Nunes, Amy V. Lynch, Hongying Yang, Heidi L. Galonek, Kristine Israelian, Wendy Choy, André Iffland, Siva Lavu, Oliver Medvedik, David Sinclair, Jerrold M. Olefsky, Michael R. Jirousek, Peter J. Elliott, Christoph Westphal - Nature 2007 cited by 1,700

  4. Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice

    Authors: Sarah J. Mitchell, Michel Bernier, Miguel A. Aon, Sonia Cortassa, Eun Young Kim, Evandro Fei Fang, Hector H. Palacios, Ahmed Ali, Ignacio Navas‐Enamorado, Andrea Di Francesco, Tamzin Kaiser, Tyler B. Waltz, Ning Zhang, James L. Ellis, Peter J. Elliott, David W. Frederick, Vilhelm A. Bohr, Mark S. Schmidt, Charles Brenner, David Sinclair, Anthony A. Sauve, Joseph A. Baur, Rafael de Cabo - Cell Metabolism 2018 cited by 334

  5. A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

    Authors: Rakesh Popat, Torben Plesner, Faith E. Davies, Gordon Cook, Mark Cook, Peter J. Elliott, Eric Jacobson, Todd Gumbleton, Heather Oakervee, Jamie Cavenagh - British Journal of Haematology 2012 cited by 220

  6. Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span

    Authors: Kevin J. Pearson, Joseph A. Baur, Kaitlyn N. Lewis, Leonid Peshkin, Nathan L. Price, Nazar Labinskyy, William R. Swindell, Davida Kamara, Robin K. Minor, Evelyn Perez, Hamish A. Jamieson, Yongqing Zhang, Stephen Dunn, Kumar Sharma, Nancy Pleshko, Laura A. Woollett, Anna Csiszár, Yuji Ikeno, David G. Le Couteur, Peter J. Elliott, Kevin G. Becker, Plácido Navas, Donald K. Ingram, Norman S. Wolf, Zoltán Ungvári, David Sinclair, Rafael de Cabo - Cell Metabolism 2008 cited by 1,151

  7. SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass

    Authors: Evi M. Mercken, Sarah J. Mitchell, Alejandro Martín‐Montalvo, Robin K. Minor, Maria Almeida, Ana P. Gomes, Morten Scheibye‐Knudsen, Hector H. Palacios, Jordan J. Licata, Yongqing Zhang, Kevin G. Becker, Husam Khraiwesh, José A. González‐Reyes, José M. Villalba, Joseph A. Baur, Peter J. Elliott, Christoph Westphal, George P. Vlasuk, James L. Ellis, David Sinclair, Michel Bernier, Rafael de Cabo - Aging Cell 2014 cited by 238

  8. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation

    Authors: Jérôme N. Feige, Marie Lagouge, Carles Cantó, Axelle Strehle, Sander M. Houten, Jill C. Milne, Philip Lambert, Chikage Mataki, Peter J. Elliott, Johan Auwerx - Cell Metabolism 2008 cited by 712

  9. Proteasome inhibitors: a novel class of potent and effective antitumor agents.

    Authors: Julian Adams, Vito J. Palombella, Edward A. Sausville, J I Johnson, Antonia T. Destree, Douglas Lazarus, Jochen Maas, Christine Pien, S Prakash, Peter J. Elliott - 1999 cited by 1,481

  10. SRT1720 improves survival and healthspan of obese mice

    Authors: Robin K. Minor, Joseph A. Baur, Ana P. Gomes, Theresa M. Ward, Anna Csiszár, Evi M. Mercken, Kotb Abdelmohsen, Yu‐Kyong Shin, Carles Cantó, Morten Scheibye‐Knudsen, Melissa Krawczyk, Pablo M. Irusta, Alejandro Martín‐Montalvo, Basil P. Hubbard, Yongqing Zhang, Elin Lehrmann, Alexa A. White, Nathan L. Price, William R. Swindell, Kevin J. Pearson, Kevin G. Becker, Vilhelm A. Bohr, Myriam Gorospe, Josephine M. Egan, Mark I. Talan, Johan Auwerx, Christoph Westphal, James L. Ellis, Zoltán Ungvári, George P. Vlasuk, Peter J. Elliott, David Sinclair, Rafael de Cabo - Scientific Reports 2011 cited by 290

  11. Systematic discovery of multicomponent therapeutics

    Authors: Alexis A. Borisy, Peter J. Elliott, Nicole W. Hurst, Margaret Lee, Joseph Lehár, Edward Price, George N. Serbedzija, Grant R. Zimmermann, Michael Foley, Brent R. Stockwell, Curtis T. Keith - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 631

  12. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

    Authors: Teru Hideshima, Paul G. Richardson, D Chauhan, Vito J. Palombella, Peter J. Elliott, Julian Adams, K C Anderson - 2001 cited by 1,530

  13. Pharmacokinetics and tolerability of SRT2104, a first‐in‐class small molecule activator of SIRT1, after single and repeated oral administration in man

    Authors: Ethan Hoffmann, J. Wald, Siva Lavu, John G. Roberts, Claire Beaumont, Jon Haddad, Peter J. Elliott, Christoph Westphal, Eric Jacobson - British Journal of Clinical Pharmacology 2012 cited by 126

  14. A phase II, randomized, placebo‐controlled, double‐blind, multi‐dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes

    Authors: A Baksi, O. V. Kraydashenko, Alsu Zalevkaya, Roman Stets, Peter J. Elliott, Jonathan Haddad, Ethan Hoffmann, George P. Vlasuk, Eric Jacobson - British Journal of Clinical Pharmacology 2014 cited by 86

  15. Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

    Authors: Robert Z. Orlowski, Thomas E. Stinchcombe, Beverly S. Mitchell, Thomas C. Shea, Albert S. Baldwin, Stephanie Stahl, Julian Adams, Dixie‐Lee Esseltine, Peter J. Elliott, Christine Pien, Roberto Guerciolini, Jessica Anderson, Natalie D. Depcik‐Smith, Rita Bhagat, Mary Jo Lehman, Steven Novick, Owen A. O’Connor, Steven L. Soignet - Journal of Clinical Oncology 2002 cited by 763

  16. Sirtuins — novel therapeutic targets to treat age-associated diseases

    Authors: Siva Lavu, Olivier Boss, Peter J. Elliott, Philip Lambert - Nature Reviews Drug Discovery 2008 cited by 424

  17. Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis

    Authors: Kenneth S. Shindler, Elvira Ventura, Mahasweta Dutt, Peter J. Elliott, Denise Fitzgerald, Abdolmohamad Rostami - Journal of Neuro-Ophthalmology 2010 cited by 204

  18. SIRT1 Activation Confers Neuroprotection in Experimental Optic Neuritis

    Authors: Kenneth S. Shindler, Elvira Ventura, Tonia S. Rex, Peter J. Elliott, Abdolmohamad Rostami - Investigative Ophthalmology & Visual Science 2007 cited by 173

  19. Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia

    Authors: Martijn D. de Kruif, Lucienne C.J.M. Lemaire, Ida A. J. Giebelen, Marieke A. D. van Zoelen, Jennie M. Pater, Petra S. van den Pangaart, A.P. de Groot, Alex F. de Vos, Peter J. Elliott, Joost C.M. Meijers, Marcel Levi, Tom van der Poll - The Journal of Immunology 2007 cited by 105

  20. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

    Authors: Yi He Ling, Leonard Liebes, Jian Jiang, James F. Holland, Peter J. Elliott, Julian Adams, Franco M. Muggia, Román Pérez-Soler - 2003 cited by 262

  21. Quantitative Real-Time RT—PCR Analysis of Inflammatory Gene Expression Associated with Ischemia—Reperfusion Brain Injury

    Authors: Rossana Berti, Anthony J. Williams, John R. Moffett, Sarah Hale, Luisa C. Velarde, Peter J. Elliott, Changping Yao, Jitendra R. Dave, Frank C. Tortella - Journal of Cerebral Blood Flow & Metabolism 2002 cited by 235

  22. The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action

    Authors: Margaret Lee, Lisa M. Johansen, Yanzhen Zhang, Amy L. Wilson, Mitchell Keegan, William Avery, Peter J. Elliott, Alexis A. Borisy, Curtis T. Keith - Cancer Research 2007 cited by 112

  23. Combining a High Dose of Metformin With the SIRT1 Activator, SRT1720, Reduces Life Span in Aged Mice Fed a High-Fat Diet

    Authors: Dushani L. Palliyaguru, Robin K. Minor, Sarah J. Mitchell, Hector H. Palacios, Jordan J. Licata, Theresa M. Ward, Gelareh Abulwerdi, Peter J. Elliott, Christoph Westphal, James L. Ellis, David Sinclair, Nathan L. Price, Michel Bernier, Rafael de Cabo - The Journals of Gerontology Series A 2020 cited by 23

  24. Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis

    Authors: Vito J. Palombella, Elaine M. Conner, John W. Fuseler, Antonia T. Destree, Jonathan M. Davis, F. Stephen Laroux, Robert Wolf, Jianqing Huang, Stephen Brand, Peter J. Elliott, Douglas Lazarus, Teresa A. McCormack, Lana Parent, Ross L. Stein, Julian Adams, Matthew B. Grisham - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 286